Home > Research > Publications & Outputs > Receipt of psychotropic medication by people wi...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Receipt of psychotropic medication by people with intellectual disability in residential settings

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Receipt of psychotropic medication by people with intellectual disability in residential settings. / Robertson, J ; Emerson, E ; Gregory, N et al.
In: Journal of Intellectual Disability Research, Vol. 44, No. 6, 12.2000, p. 666-676.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Robertson, J, Emerson, E, Gregory, N, Hatton, C, Kessissoglou, S & Hallam, A 2000, 'Receipt of psychotropic medication by people with intellectual disability in residential settings', Journal of Intellectual Disability Research, vol. 44, no. 6, pp. 666-676. https://doi.org/10.1111/j.1365-2788.2000.00307.x

APA

Robertson, J., Emerson, E., Gregory, N., Hatton, C., Kessissoglou, S., & Hallam, A. (2000). Receipt of psychotropic medication by people with intellectual disability in residential settings. Journal of Intellectual Disability Research, 44(6), 666-676. https://doi.org/10.1111/j.1365-2788.2000.00307.x

Vancouver

Robertson J, Emerson E, Gregory N, Hatton C, Kessissoglou S, Hallam A. Receipt of psychotropic medication by people with intellectual disability in residential settings. Journal of Intellectual Disability Research. 2000 Dec;44(6):666-676. doi: 10.1111/j.1365-2788.2000.00307.x

Author

Robertson, J ; Emerson, E ; Gregory, N et al. / Receipt of psychotropic medication by people with intellectual disability in residential settings. In: Journal of Intellectual Disability Research. 2000 ; Vol. 44, No. 6. pp. 666-676.

Bibtex

@article{a102fa4a2d06405b9d06a250d51dedeb,
title = "Receipt of psychotropic medication by people with intellectual disability in residential settings",
abstract = "Previous studies have reported that the rate of prescription of antipsychotic medication for people with intellectual disability is far in excess of the expected prevalence of psychoses for this population. Recent research identifying factors which predict the use of psychotropic medication suggests that challenging behaviour may play a key role in determining the receipt of antipsychotic medication. The present study reports the prevalence of psychoactive medication receipt for 500 people with intellectual disability living in different forms of residential provision in the UK. Variables which predict the receipt of psychotropic medication are also identified. The results show differences between forms of residential provision in rates of medication receipt. Analyses of predictors of psychotropic medication receipt suggest that, whilst the receipt of antidepressants is predicted by symptoms of mental ill health, the receipt of both antipsychotics and hypnotics/anxiolytics is predicted by variables related to challenging behaviour.",
keywords = "antidepressants, antipsychotics, hypnotics/anxiolytics, intellectual disability psychotropic medication, residential settings, MENTALLY-RETARDED PERSONS, DRUG-USE, LEARNING-DISABILITIES, ANTIPSYCHOTIC MEDICATION, CHALLENGING BEHAVIOR, RETARDATION, ADULTS, COMMUNITY, DOSAGE, PRESCRIPTION",
author = "J Robertson and E Emerson and N Gregory and C Hatton and S Kessissoglou and A Hallam",
year = "2000",
month = dec,
doi = "10.1111/j.1365-2788.2000.00307.x",
language = "English",
volume = "44",
pages = "666--676",
journal = "Journal of Intellectual Disability Research",
issn = "0964-2633",
publisher = "Blackwell Publishing Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - Receipt of psychotropic medication by people with intellectual disability in residential settings

AU - Robertson, J

AU - Emerson, E

AU - Gregory, N

AU - Hatton, C

AU - Kessissoglou, S

AU - Hallam, A

PY - 2000/12

Y1 - 2000/12

N2 - Previous studies have reported that the rate of prescription of antipsychotic medication for people with intellectual disability is far in excess of the expected prevalence of psychoses for this population. Recent research identifying factors which predict the use of psychotropic medication suggests that challenging behaviour may play a key role in determining the receipt of antipsychotic medication. The present study reports the prevalence of psychoactive medication receipt for 500 people with intellectual disability living in different forms of residential provision in the UK. Variables which predict the receipt of psychotropic medication are also identified. The results show differences between forms of residential provision in rates of medication receipt. Analyses of predictors of psychotropic medication receipt suggest that, whilst the receipt of antidepressants is predicted by symptoms of mental ill health, the receipt of both antipsychotics and hypnotics/anxiolytics is predicted by variables related to challenging behaviour.

AB - Previous studies have reported that the rate of prescription of antipsychotic medication for people with intellectual disability is far in excess of the expected prevalence of psychoses for this population. Recent research identifying factors which predict the use of psychotropic medication suggests that challenging behaviour may play a key role in determining the receipt of antipsychotic medication. The present study reports the prevalence of psychoactive medication receipt for 500 people with intellectual disability living in different forms of residential provision in the UK. Variables which predict the receipt of psychotropic medication are also identified. The results show differences between forms of residential provision in rates of medication receipt. Analyses of predictors of psychotropic medication receipt suggest that, whilst the receipt of antidepressants is predicted by symptoms of mental ill health, the receipt of both antipsychotics and hypnotics/anxiolytics is predicted by variables related to challenging behaviour.

KW - antidepressants

KW - antipsychotics

KW - hypnotics/anxiolytics

KW - intellectual disability psychotropic medication

KW - residential settings

KW - MENTALLY-RETARDED PERSONS

KW - DRUG-USE

KW - LEARNING-DISABILITIES

KW - ANTIPSYCHOTIC MEDICATION

KW - CHALLENGING BEHAVIOR

KW - RETARDATION

KW - ADULTS

KW - COMMUNITY

KW - DOSAGE

KW - PRESCRIPTION

U2 - 10.1111/j.1365-2788.2000.00307.x

DO - 10.1111/j.1365-2788.2000.00307.x

M3 - Journal article

VL - 44

SP - 666

EP - 676

JO - Journal of Intellectual Disability Research

JF - Journal of Intellectual Disability Research

SN - 0964-2633

IS - 6

ER -